pDNA/rVSV vector vaccine (Profectus)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamepDNA/rVSV vector vaccine (Profectus)

Drug Alias NameHCV vaccine (Profectus)plasmid DNA/recombinant vesicular stomatitis virus vector vaccine (Profectus)

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth Pharmaceuticals Co

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth Pharmaceuticals Co +[2]

Active IndicationsN/A

Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A